| NMN | N-Methyl-Nicotinamide |
|---|---|
| NMN | nicotinamide mononucleotide; normetanephrine |
| NMNRU | National Medical Neuropsychiatric Research Unit |
| nmol | nanomole |
| NMOR | nemadione oxidoreductase; N-nitrosomorpholine |
| NMOS | N-type metal oxide semiconductor |
| NMP | normal menstrual period; nucleoside monophosphate |
| NMPCA | nonmetric principal component analysis |
| NMPTP | N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NMR | Nuclear Magnetic Resonance; ÇÙÀڱ⠰ø¸í¼ú |
| NMD | Neuronal migration disorders |
|---|---|
| NMD | Nonsense-mediated mRNA decay |
| NMDA | N -methyl- D -aspartate |
| NMDA | N -methyl-D-aspartic acid |
| NMDA | N-methyl-D-aspartate receptor |
| NMDA | Non-N-methyl-D-aspartate |
| NMDA-R | NMDA receptor |
| NMDAR | N-Methyl-D-aspartate receptor |
| NMDAR1 | N-methyl- D-aspartate receptor subunit 1 |
| NMDAR1 | N-methyl-D-aspartate receptor 1 |
| NMR |
Non-Magnetic Resonance
Ãâó: www.fas.org/spp/military/docops/usaf/2020/app-v.ht...
|
|---|---|
| NMR |
a form of spectroscopy which depends on the absorption and emission of energy arising from changes in the spin states of the nucleus of an atom. [For aggregates of atoms, as in molecules, minor variations in these energy changes are caused by the local chemical environment. The energy changes used are in the radiofrequency range of the electromagnetic spectrum and depend upon the magnitude of an applied magnetic field.]
Ãâó: www.cartage.org.lb/en/themes/Sciences/Chemistry/Or...
|
| nm |
abbreviation for nanometer.
Ãâó: www.sgia.org/glossary/Nn.cfm
|
| NMR |
Nuclear Magnetic Resonance, a technique to identify atoms in a sample by measuring the signal given off by the relaxation of eg protons previously aligned in a strong magnetic field.
Ãâó: www.food.gov.uk/science/ouradvisors/toxicity/cotme...
|
| nm |
Nodular Melanoma
Ãâó: www.cancerindex.org/medterm/medtm5.htm
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|